INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Results of Operations and Financial ConditionItem 2.02 –Results of Operations and Financial Condition
On July 17, 2018, the Company issued a press release reporting our preliminary expected financial results for the second quarter ended June 30, 2018. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 – Financial Statements and Exhibits
Press release issued July 17, 2018, reporting preliminary expected financial results for the second quarter ended June 30, 2018
INNOVUS PHARMACEUTICALS, INC. ExhibitEX-99.1 2 ex99-1.htm PRESS RELEASE Blueprint Exhibit 99.1 Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of $6.6 million to $6.8 million Preliminary Quarterly Revenue Increase of 47-51% and Comparable 2017 Second Quarter Increase of 330-340% and Fiscal Year 2018 Net Revenue Annual Guidance Adjusted Upwards to at Least $22 Million SAN DIEGO,…To view the full exhibit click